Enteral Feeding Tube Placement


Goals/Objectives

  • Rationale for Enteral vs Parenteral

  • Indications

  • Modes of delivery

  • Complications

Metabolism in Surgical Patients

Ahmed Al-Mousawi
Noe A. Rodriguez
David N. Herndon

From Townsend CM: Sabiston Textbook of Surgery, 19th edition (Saunders 2012)

Nutritional Support

Surgical patients with suboptimal nutritional support have impaired wound healing, altered immune responses, accelerated catabolism, increased organ dysfunction, delayed recovery, and increased morbidity and mortality. Following surgery, patients who are inadequately fed become undernourished within 10 days and display a marked increase in mortality. Feeding should therefore be initiated as early as possible, address elevated nutritional demands, and offset any pre-existing nutritional impairment. The ultimate goal of perioperative nutritional management is to supplement caloric and nutrient-specific requirements safely to promote wound healing, diminish risk of infection, and prevent loss of muscle protein.

Initiating Nutritional Support

Nutritional support should be considered for all patients according to clinical assessment and guidelines over the perioperative period ( Box 64-1-1 ). If a surgical intervention can be delayed, 10 to 14 days of nutritional support for patients with severe nutritional risk has been shown to be beneficial prior to surgery. Obviously critical patients and those with a significant loss in body weight or a premorbid state should receive support almost immediately (<3 days) after admission, because they often exhibit immunologic impairment and are at increased risk of infection. Significant weight loss in these patients is often associated with a reduced chance of survival. Malnourished surgical patients also have severely impaired wound healing times. In addition to requiring nutritional support, severely hypercatabolic patients may require therapeutic interventions and rehabilitation exercise programs to regain muscle mass.

Box 64-1-1
Criteria to Initiate Perioperative Nutritional Support

Severe nutritional risk expected with at least one of the following:

  • Past medical history: severe undernutrition, chronic disease.

  • Involuntary loss >10%–15% of usual body weight within 6 mo or >5% within 1 mo

  • Expected blood loss >500 mL during surgery

  • Weight of 20% under IBW or BMI <18.5 kg/m 2

  • Failure to thrive on pediatric growth and development curves (<5th percentile or a trend line crossing two major percentile lines)

  • Serum albumin <3.0 g/dL or transferrin <200 mg/dL in the absence of an inflammatory state, hepatic dysfunction, or renal dysfunction

  • Anticipate that patient will be unable to meet caloric requirements within 7–10 days perioperatively.

  • Catabolic disease (e.g., significant burns or trauma, sepsis, and pancreatitis)

Principles Guiding Routes of Nutrition

After a decision to initiate support has been reached, a route of administration should be carefully selected, with the following considerations ( Fig. 64-1-1 ) :

  • 1.

    Use the oral route if the GI tract is fully functional and there are no other contraindications to oral feeding.

  • 2.

    Initiate nutrition via the enteral route if the patient is not expected to be on a full oral diet within 7 days post-surgery and there are no GI tract contraindications ( Box 64-1-2 ).

    Box 64-1-2
    Adapted from Villet S, Chiolero RL, Bollmann MD, et al: Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients. Clin Nutr 24:502–509, 2005.
    Contraindications to Enteral Nutrition

    • Intractable vomiting, diarrhea refractory to medical management

    • Paralytic ileus

    • Distal high-output intestinal fistulas (too distal to bypass with feeding tube)

    • GI obstruction, ischemia

    • Diffuse peritonitis

    • Severe shock or hemodynamic instability

    • Severe GI hemorrhage

    • Severe short bowel syndrome (less than 100 cm of small bowel remaining)

    • Severe GI malabsorption (e.g., enteral nutrition failed, as evidenced by progressive deterioration in nutritional status)

    • Inability to gain access to GI tract

    • Need is expected for <7 days

  • 3.

    If the enteral route is contraindicated or not tolerated, use the parenteral route within 24 to 48 hours in patients who are not expected to be able to tolerate full enteral nutrition (EN) within 7 days.

  • 4.

    Administer at least 20% of the caloric and protein requirements enterally while reaching the required goal with additional PN.

  • 5.

    Maintain PN until the patient is able to tolerate 75% of calories through the enteral route and EN until the patient is able to tolerate 75% of calories via the oral route.

F igure 64-1-1, Algorithm for route of nutritional support in surgical patients.

Enteral Nutrition

Early (24 to 48 hours) institution of EN following major surgery minimizes the risk of undernutrition and can abate the hypermetabolic response seen after surgery. Administration of EN can be accomplished via various routes, including the use of nasogastric (NG), nasoduodenal, and nasojejunal tubes ( Fig. 64-1-2 ), which are preferentially used in patients who are expected to require support for short time periods (<4 weeks). Other surgical options include open or percutaneous gastrostomy and jejun­ostomy, usually for those patients who are expected to require long-term EN (>4 weeks). In general, EN offers the beneficial effects of trophic feedings, which include structural maintenance and functional support of the intestinal mucosa, achieved by providing nutrients such as glutamine, preserving blood supply, and promoting peristalsis. Use of EN to protect and maintain the integrity of the intestinal mucosa may therefore help reduce the risk of sepsis caused by bacterial translocation. Feeding routes for the delivery of EN are described in Table 64-1-1 .

F igure 64-1-2, Nasogastric and nasojejunal tube positions.

T able 64-1-1
Enteral Nutrition Feeding Routes
Adapted from Al-Mousawi A, Branski LK, Andel HL, et al: Ernährungstherapie bei Brandverletzten. In Kamolz LP, Herndon DN, Jeschke MG (eds): Verbrennungen: Diagnose, Therapie und Rehabilitation des thermischen Traumas, German Edition, New York, 2009, Springer-Verlag, pp 183–194.
Route Suitability Insertion Method, Confirmation Advantages Disadvantages
Nasogastric Short term – functional GI tract Blind at bedside; fluoroscopy guided Easy to insert, replace; can monitor gastric pH and residual volume; bolus feeding Aspiration risk, misplacement complications, sinusitis, epistaxis, nasal necrosis, esophageal strictures, erosive esophagitis
Nasoduodenal, nasojejunal Short term – functional GI tract but poor gastric emptying, reflux, aspiration risk; commence feed only when volume-resuscitated and hemodynamically stable Blind at bedside; fluoroscopy guided, endoscopy guided Reduced aspiration risk; some tubes enable decompression of stomach while feeding into jejunum Easily clogged or displaced, aspiration risk, misplacement complications, displacement and reflux into stomach, sinusitis, epistaxis, nasal necrosis; requires continuous infusion; cannot check gastric residuals except with specialized gastric port
Gastrostomy Long term – good gastric emptying; avoid if significant reflux or aspiration problem Surgical, percutaneous, endoscopic, radiologic Bolus feeding; large-bore tube less likely to block Procedure risks include bleeding, perforation, aspiration risk, dislodgment with peritoneal contamination, wound site infection, granulation
Jejunostomy Long term – functional GI tract but poor gastric emptying, reflux, aspiration risk, gastroparesis or gastric dysfunction Surgical, percutaneous, endoscopic, radiologic Reduced aspiration risk Bleeding, infection, perforation, migration, aspiration, dislodgement and leakage into peritoneal cavity, occlusion, pneumatosis, intestinal ischemia or infarction, bowel obstruction; difficult to replace; cannot check residuals; requires continuous infusion

In the critically ill patient, EN should be initiated within 48 hours of injury or admission; average intake delivered within the first week should be at least 60% to 70% of the total estimated energy requirements, as determined by the assessment. Provision of EN in this time frame and at this level may be associated with decreased length of hospital stay, days on mechanical ventilation, and infectious complications.

Feeding through a NG tube is the most cost-effective method for EN support and perhaps the most helpful for preventing postoperative complications, such as gastroparesis. The use of NG tubes conveniently facilitates the ability to supply caloric needs and to monitor the volume of gastric residuals. To decrease reflux and the risk of aspiration, it is recommended that the head of the bed be raised to 45 degrees and the volume of residuals not exceed 50 mL/hour. Although the residual volume should be rechecked after 1 hour from a single elevated value, feeding does not have to stop automatically.

GI ileus may reflect an underlying deterioration; therefore, monitoring gastric residual volumes serves as an indicator of intercurrent conditions, such as sepsis. In burn patients, residuals that increase above the amount of food delivered routinely every hour have been shown to correlate with the development of bacterial sepsis, and a full sepsis workup is indicated when gastric residuals exceed 200 mL.

The practice of checking the positioning of tubes by X-ray prior to their use is a time-consuming process that has been motivated, in part, by the unintended placement of small-diameter tubes into lower airways. However, NG tubes may be placed with confidence by auscultation over the stomach while delivering 50 mL of air quickly with an irrigation syringe. Nasojejunal and duodenal tubes may be too small for this procedure. Contraindications to EN include prolonged ileus or gastroparesis, bowel obstruction, acute pseudo-obstruction, ischemic enterocolitis, and other causes of malabsorption.

With nasoenteric feeding beyond the stomach, the tube should be advanced through the duodenum, ideally past the ligament of Treitz to the proximal jejunum, because this reduces the risk of aspiration. Nasojejunal feeding may be preferable in some settings because it does not need to be stopped prior to surgery to prevent aspiration. However, nasojejunal feeding requires continuous infusion, and gastric residual volumes cannot be checked to confirm progress. Nasojejunal feeding should not be commenced until the patient is fully volume-resuscitated and hemodynamically stable. Percutaneous feeding options should be considered if a patient requires nasal tube feeding for a prolonged period beyond 2 or 3 weeks.

Ileus associated with severe injury is not as common as previously thought. Ileus derived from mesenteric hypoperfusion prior to adequate resuscitation is reversed once the patient has been resuscitated. Conversely, over-resuscitation leads to GI edema and should also be avoided. Postinjury ileus does not affect the small bowel as profoundly as the stomach. Therefore, feeding using a nasoduodenal tube passed through the pylorus, or a nasojejunal tube advanced past the ligament of Treitz, can be initiated as soon as possible, preferably within 6 hours following injury. This approach also allows continuous feeding during surgeries and physical therapy sessions. The initiation of immediate enteral feeding allows the delivery of calculated caloric requirements by the third day postinjury. Reduction of hypermetabolism by initiating enteral feeding soon after injury is possible, with this reduction in metabolic rate associated with less intense elevations in glucagon, cortisol, and catecholamine levels.

Formulations

Numerous enteral formulations are available and can be classified according to their composition. Standard formulas are sterile, nutritionally complete, and intended for patients with a normal GI tract who cannot ingest adequate nutrients and calories by regular oral diets. Specialty formulations may be more efficiently absorbed in patients suffering from short gut syndrome, severe trauma, burn injury, and chronic malabsorptive diarrhea. Whole-protein formulations are appropriate for most patients. Peptide-based or free amino acid formulations may be considered for patients with a severely compromised GI tract or severe protein-fat malabsorption. Modular formulas consist of a singular macronutrient as a source of calories (e.g., fiber, protein) and are generally used by mixing with standard or specialty formulas. Immune-enhancing formulas consist of nutritional components enriched with arginine, glutamine, nucleotides, and omega-3 fatty acids. Although most formulations are hyperosmolar at full strength, dilution by 25% to 50% to make isotonic and hypotonic formulas is initially preferred to minimize the possibility of diarrhea from excess osmotic load and to facilitate absorption ( Table 64-1-2 ). Continuous enteral feeding with milk or a soy-based milk substitute can maintain total body weight throughout the hospital course but may not be able to maintain lean body mass.

T able 64-1-2
Composition of Various Enteral Nutrition Formulations *
Adapted from Al-Mousawi A, Branski LK, Andel HL, et al: Ernährungstherapie bei Brandverletzten. In Kamolz LP, Herndon DN, Jeschke MG (eds): Verbrennungen: Diagnose, Therapie und Rehabilitation des thermischen Traumas, German edition, New York, Springer-Verlag, 2009, pp 183–194.
COMPOSITION
Formula kcal/mL CHO, g/L (% Calories) PRO, g/L (% Calories) Fat, g/L (% Calories) Osmolarity (mOsm/L) Comments
Standard
Similac 0.67 72 (43) 15 (8) 36 (49) Infant nutrition
Enfamil 0.67 73 (44) 14 (8) 35 (48) Infant nutrition
Isomil 0.67 68 (41) 18 (10) 37 (49) Infant nutrition, lactose-free, used in cow protein allergy
Isosource HN 1.2 160 (53) 53 (18) 39 (29) 490 High nitrogen
Ensure Plus 1.5 208 (57) 54 (15) 46 (28) 680 Concentrated calories
Pediasure Enteral 1.0 133 (53) 30 (12) 40 (35) 335 For ages 1–13 yr, with fiber, not easily digestible
Jevity 1 Cal 1.06 155 (54) 44 (17) 35 (29) 300 Isotonic nutrition with fiber
Boost Kid Essential 1.0 135 (54) 30 (12) 38 (34) 550–600 Oral or tube feeding
Boost HP 1.0 137 (55) 62 (24) 25 (21) 650 Oral or tube feeding, high protein
Promote 1.0 130 (52) 62 (25) 26 (23) 340 High protein, oral or tube feeding
Promote w/Fiber 1.0 138 (50) 62 (25) 28 (25) 380 Very high protein, oral or tube feeding
Nutren 1.0 1.0 127 (51) 40 (16) 38 (33) 370 With fiber, decreases diarrhea
Immune-Enhancing
Crucial 1.5 89 (36) 63 (25) 45 (39) 490 With ARG, critical illness, major surgery, transitional feedings, hydrolyzed protein
Impact 1.0 130 (53) 56 (22) 28 (25) 375 With ARG, GLN, and fiber
Impact GLN 1.3 150 (46) 78 (24) 43 (30) 630 Immunonutrition, GLN, ARG, omega-3 PUFA, nucleic acids
Oxepa 1.5 105 (28) 63 (17) 94 (55) 535 ARDS, acute lung injury, sepsis; concentrated
Specialty
Glucerna 1.0 96 (34) 42 (17) 54 (49) 355 For glucose-intolerant or diabetic patients, low CHO
Nepro 1.8 167 (34) 81 (18) 96 (48) 585 For CKD and patients on dialysis; concentrated
Osmolite 1 Cal 1.06 144 (54) 44 (17) 35 (29) 300 Isotonic, for use in those intolerant to hyperosmolar nutrition
Vivonex RTF 1.0 175 (70) 50 (20) 12 (10) 630 Transitional feeding, low fat, easily digestible
Vivonex TEN 1.0 210 (82) 38 (15) 2.8 (3) 630 100% free amino acids, very low fat, used for severe trauma (e.g., burns) or surgery, transitional feeding
Vivonex Plus 1.0 190 (76) 45 (18) 6.7 (6) 650 100% free amino acids, very low fat, used for severe trauma (e.g., burns) or surgery, transitional feeding
Elecare 0.67 72 (43) 20 (15) 32 (42) 350 Prepared at 9.4 g/60 mL; amino acid-based nutrition
Modular
Resource Benefiber 0.27 66 (100) 0% 0% Prepared at 4 g/60 mL; tasteless, odorless, soluble fiber, used for constipation
Resource Beneprotein 0.83 0% 200 (100) 0% Prepared at 7 g/30 mL; whey protein, mixed in foods, protein-calorie malnutrition
ARDS, Acute respiratory distress syndrome; ARG, arginine; CHO, carbohydrate; CKD, chronic kidney disease; GLN, glutamine; PRO, protein.

* Data extrapolated from Nestle Clinical Nutrition: Enteral product reference guide, Nestle, 2010, Minneapolis; and Abbott Laboratories: Abbott nutrition pocket guide, Abbott Park, Ill, 2009, Abbott Laboratories.

In patients undergoing a severe hypermetabolic response, peripheral breakdown of fat is increased. Fatty acids are delivered to the liver and undergo re-esterification; their accumulation leads to fatty liver changes. The use of high-fat diets such as milk, which consists of 44% fat, 42% carbohydrate, and 14% protein, needs to be carefully considered because additional fat may lead to increased levels of fat in the liver. The use of high-sugar, high-protein diets consisting of 3% fat, 82% carbohydrate, and 15% protein stimulate protein synthesis, increase endogenous insulin production, and improve lean body mass accretion.

Muscle protein degradation is markedly decreased with the administration of a high-carbohydrate diet compared with fat-containing diets. Endogenous insulin concentration is increased, improving the net balance of skeletal muscle protein caused by decreased protein breakdown.

Complications

Complications of nasogastric and enteric feeding include nausea and vomiting, epistaxis, sinusitis, nasal necrosis, aspiration leading to pneumonia, tube malpositioning, dislodgment, and feeding-associated diarrhea. Fine-bore tubes are more comfortable but can become blocked easily. Auscultation examination of gastric fluid aspirate and pH testing can be used to confirm tube position, particularly for large-bore nasal tubes, although many units prefer radiologic confirmation. Tubes can also be inserted under endoscopic or fluoroscopic guidance. Monitoring guidelines and potential metabolic complications of EN are given in Tables 64-1-3 and 64-1-4 .

T able 64-1-3
Suggested Monitoring Schedule for Enteral Feeding
Parameter Acute Patient Stable Patient
Electrolytes Daily 1–2×/week
Complete blood count Daily 1–2×/week
Glucose level 3×/day; more often if poor control 3×/day; less often if good control
Creatinine and urea levels Daily Weekly or twice weekly
Nitrogen balance Daily 2–3×/week
Input and output Daily 2–3×/week
Body weight Daily 2–3×/week
Urine output Hourly every 4 hours
Stool Per motion Daily

T able 64-1-4
Complications of Enteral Feeding
Problem Common Causes Management
Diarrhea Medications (e.g., antibiotics, H 2 blockers, laxatives, hyperosmotic, hypertonic solutions), feeding intolerance (osmolarity, fat), acquired lactase deficiency
  • Measure stool output.

  • Rule out infection (bacterial, viral, parasitic).

  • Supply fiber.

  • Change medication or formula.

  • Check osmolarity and infusion rate.

  • Administer antimotility medications (e.g., loperamide, codeine).

Nausea and vomiting Delayed stomach emptying, constipation, abdominal distention, odor and appearance of formulations
  • Administer feedings at room temperature.

  • Use isotonic formulations.

  • Use a closed system when possible.

  • Reduce doses of narcotics.

  • Use gastroprokinetic agents (metoclopramide).

  • Monitor gastric residuals and stool output.

Constipation, fecal impaction Dehydration, lack or excess of fiber
  • Monitor fluid balance daily.

  • Carry out rectal disimpaction.

  • Consider the use of cathartics, stool softeners, laxatives, or enemas.

Aspiration pneumonitis Long-term supine position, delayed stomach emptying, altered mental status, malpositioned feeding tube, vomiting
  • Place head of bed at 45 degrees during feedings.

  • Stop EN if gastric residual volume exceeds 200 mL.

  • Use nasoduodenal or nasojejunal tubes in patients at risk.

Hyponatremia overhydration Excess fluid intake, refeeding syndrome, organ failure (e.g., liver, heart, kidney)
  • Monitor fluid balance and body weight daily.

  • Consider fluid restriction.

  • Change formula (avoid low-sodium intake).

  • Initiate diuretic therapy.

Hypernatremia Dehydration, inadequate fluid intake Increase free water.
Dehydration Diarrhea, inadequate fluid intake
  • Determine cause.

  • Increase fluid intake.

Hyperglycemia High content of carbohydrate in feedings, insulin resistance
  • Evaluate and adjust feeding formula.

  • Consider insulin regimen.

Hypokalemia, hypophosphatemia, hypomagnesemia Diarrhea, refeeding syndrome
  • Correct electrolyte abnormalities.

  • Determine cause.

  • Reduce rate if refeeding syndrome is present and monitor patient.

Hyperkalemia Excess potassium intake, renal impairment
  • Change feeding formula.

  • Reduce potassium intake.

  • Consider insulin regimen.

Refeeding syndrome can be precipitated following prolonged fasting and IV fluid administration in chronically malnourished patients. The transition from metabolizing body fat to carbohydrate in the feed can cause an abrupt rise in insulin and disturbances of intracellular electrolytes. Electrolyte abnormalities can result in cardiac failure and dysrhythmias, respiratory failure, neurologic disturbances, and renal and hepatic dysfunction. With all nutritional support, the rate of feeding should commence slowly to prevent abrupt metabolic changes.

Aside from mechanical issues related to the feeding tube, the most common complications of enteral feedings result from solute overload. Inappropriately rapid administration of hyperosmolar solutions may result in diarrhea, dehydration, electrolyte imbalance, hyperglycemia, and loss of potassium, magnesium, and other ions through diarrhea. If aggressive administration of hyperosmolar solute continues, pneumatosis intestinalis with bowel necrosis and perforation can result. Hyperosmolar nonketotic coma can also occur with enteral feedings, as with PN.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here